Skip to main content

ORCRY · Organo Corporation · Investor Relations

Track ORCRY — free
$14.50 At close · Oct 23 Q1 2026 earnings call transcript
Market Cap
$3.33B
Shares
229.91M
Volume · Oct 23 100 Avg daily vol (3 sessions) 700

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-11-10 00:00 UTC Results briefing for the 2nd quarter of the fiscal year ended March 2027 (planned) Earnings call

Past events

Date Event Type
2026-11-04 Announcement of results for the 2nd quarter of the fiscal year ending March 2027 (planned) Results publication
2026-11-04 Announcement of results for the 2nd quarter of the fiscal year ending March 2027(planned) Results publication
2026-08-03 Announcement of results for the 1st quarter of the fiscal year ending March 2027(planned) Results publication
2026-08-03 Announcement of results for the 1st quarter of the fiscal year ending March 2027 Results publication
2026-05-14 Summary of Q&A on Financial Results Presentation Meeting for the Fiscal Year Ended March 31, 2026 Earnings call
2026-05-14 Results briefing for the fiscal year ended March 2026 Earnings call
2026-05-13 Announcement of results for the fiscal year ended March 2026 Results publication
2026-02-04 Announcement of results for the 3rd quarter of the fiscal year ending March 2026 Results publication
2025-11-04 Results briefing for the 2nd quarter of the fiscal year ended March 2026 Event
2025-10-31 Announcement of results for the 2nd quarter of the fiscal year ending March 2026 Results publication
2025-08-04 Announcement of results for the 1st quarter of the fiscal year ending March 2026 Results publication
2025-05-19 Summary of Q&A on Financial Results Presentation Meeting for the Fiscal Year Ended March 31, 2025 Earnings call
2025-05-19 Results briefing for the fiscal year ended March 2025 Event
2025-05-13 Announcement of results for the fiscal year ended March 2025 Results publication
2025-02-05 Announcement of results for the 3rd quarter of the fiscal year ending March 2025 Results publication
2024-11-05 Summary of Q&A on Financial Results Presentation Meeting for the First Half of the Fiscal Year Ending March 31, 2025 Earnings call
2024-11-05 Results briefing for the 2nd quarter of the fiscal year ended March 2025 Event
2024-11-01 Announcement of results for the 2nd quarter of the fiscal year ending March 2025 Results publication
2024-07-31 Announcement of results for the 1st quarter of the fiscal year ending March 2025 Results publication
2024-05-15 Summary of Q&A on Financial Results Presentation Meeting for the Fiscal Year Ended March 31, 2024 Earnings call
2024-05-15 Results briefing for the fiscal year ended March 2024 Event
2024-05-13 Announcement of results for the fiscal year ended March 2024 Results publication
2024-02-02 Announcement of results for the 3rd quarter of the fiscal year ending March 2024 Results publication
2023-11-01 Announcement of results for the 2nd quarter of the fiscal year ending March 2024 Results publication
2023-08-01 Announcement of results for the 1st quarter of the fiscal year ending March 2024 Results publication

Source: https://www.organo.co.jp/english/ir/

Key facts CIK 2142762 CUSIP 68590A100 Visit website Investor relations